Nuvation Bio Files 8-K on Financials
Ticker: NUVB · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1811063
Sentiment: neutral
Topics: financial-condition, results-of-operations, exhibits
Related Tickers: NUVB
TL;DR
Nuvation Bio dropped an 8-K detailing its financial condition and results. Check it out.
AI Summary
Nuvation Bio Inc. filed an 8-K on March 6, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company, formerly known as Panacea Acquisition Corp. until April 30, 2020, is incorporated in Delaware and headquartered in San Francisco, California.
Why It Matters
This 8-K filing provides an update on Nuvation Bio's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Nuvation Bio Inc. (company) — Registrant
- Panacea Acquisition Corp. (company) — Former company name
- March 6, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- San Francisco, California (location) — Business address city and state
- New York, NY (location) — Principal executive offices address city and state
FAQ
What is the primary purpose of this 8-K filing for Nuvation Bio Inc.?
The primary purpose of this 8-K filing is to report on Nuvation Bio Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 6, 2025.
What was Nuvation Bio Inc.'s former company name?
Nuvation Bio Inc.'s former company name was Panacea Acquisition Corp., with a date of name change on April 30, 2020.
In which state is Nuvation Bio Inc. incorporated?
Nuvation Bio Inc. is incorporated in Delaware.
What are the principal executive offices of Nuvation Bio Inc.?
The principal executive offices of Nuvation Bio Inc. are located at 1500 Broadway, Suite 1401, New York, NY 10036.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding Nuvation Bio Inc. (NUVB).